Background
Soy food intake may have protective effects against breast cancer risk, including estrogen receptor negative breast cancer. However, the underlying molecular mechanisms remain unclear.
Methods
To evaluate the association of soy intake with the expression of microRNAs and genes in the tumor tissue of triple-negative (lacking expression of estrogen receptor, progesterone receptor and HER2) breast cancer (TNBC) patients, a total of 800 microRNAs (miRNAs) and 302 gene expressions were measured by the NanoString nCounter Assays in formalin-fixed paraffin-embedded (FFPE) tumor tissues from 272 TNBC patients. Soy intake during the one-year period prior to cancer diagnosis was assessed by a validated food-frequency questionnaire. The association of soy intake with the expression of miRNAs and genes was evaluated by performed linear regression analysis with adjustments for patient age and TNM.
Results
A total of 14 miRNAs and 24 genes were significantly associated with soy food intake (p<0.05): 13 of the 14 miRNAs (92.9%) and 9 of 24 genes (37.5%), including tumor suppressors miR-29a-3p and IGF1R, showed over-expression for those women with a high soy intake, while the remaining miRNAs and genes, including oncogenes KRAS and FGFR4, showed under-expression. Furthermore, cell growth-related genes showed a predominant under-expression pattern when comparing tumor samples from women with a high soy food intake to samples from those who had a lower soy food intake.
Conclusions
Our study suggests that long-term pre-diagnosis soy intake may lead to increased expression of tumor suppressors and decreased expression of oncogenes, especially cell growth-related genes, in breast tumor tissues.